Literature DB >> 27702593

Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses.

Miguel A Martín-Acebes1, Ángela Vázquez-Calvo2, Juan-Carlos Saiz2.   

Abstract

Flaviviruses are emerging arthropod-borne pathogens that cause life-threatening diseases such as yellow fever, dengue, West Nile encephalitis, tick-borne encephalitis, Kyasanur Forest disease, tick-borne encephalitis, or Zika disease. This viral genus groups >50 viral species of small enveloped plus strand RNA virus that are phylogenetically closely related to hepatitis C virus. Importantly, the flavivirus life cycle is intimately associated to host cell lipids. Along this line, flaviviruses rearrange intracellular membranes from the endoplasmic-reticulum of the infected cells to develop adequate platforms for viral replication and particle biogenesis. Moreover, flaviviruses dramatically orchestrate a profound reorganization of the host cell lipid metabolism to create a favorable environment for viral multiplication. Consistently, recent work has shown the importance of specific lipid classes in flavivirus infections. For instances, fatty acid synthesis is linked to viral replication, phosphatidylserine and phosphatidylethanolamine are involved on the entry of flaviviruses, sphingolipids (ceramide and sphingomyelin) play a key role on virus assembly and pathogenesis, and cholesterol is essential for innate immunity evasion in flavivirus-infected cells. Here, we revise the current knowledge on the interactions of the flaviviruses with the cellular lipid metabolism to identify potential targets for future antiviral development aimed to combat these relevant health-threatening pathogens. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dengue virus; Flavivirus; Infection; Lipid; West Nile virus; Zika virus

Mesh:

Substances:

Year:  2016        PMID: 27702593     DOI: 10.1016/j.plipres.2016.09.005

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  49 in total

1.  Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-O-Methyl Nordihydroguaiaretic Acid against West Nile Virus and Zika Virus.

Authors:  Teresa Merino-Ramos; Nereida Jiménez de Oya; Juan-Carlos Saiz; Miguel A Martín-Acebes
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 2.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

3.  Biochemical characterization of the mouse ABCF3 protein, a partner of the flavivirus-resistance protein OAS1B.

Authors:  Elizabeth Peterson; Emma Shippee; Margo A Brinton; Parjit Kaur
Journal:  J Biol Chem       Date:  2019-08-14       Impact factor: 5.157

4.  Global Interactomics Uncovers Extensive Organellar Targeting by Zika Virus.

Authors:  Etienne Coyaud; Charlene Ranadheera; Derrick Cheng; João Gonçalves; Boris J A Dyakov; Estelle M N Laurent; Jonathan St-Germain; Laurence Pelletier; Anne-Claude Gingras; John H Brumell; Peter K Kim; David Safronetz; Brian Raught
Journal:  Mol Cell Proteomics       Date:  2018-07-23       Impact factor: 5.911

5.  Inositol-Requiring Enzyme 1α Promotes Zika Virus Infection through Regulation of Stearoyl Coenzyme A Desaturase 1-Mediated Lipid Metabolism.

Authors:  Yanxia Huang; Quanshi Lin; Zhiting Huo; Cancan Chen; Shili Zhou; Xiaocao Ma; Huixin Gao; Yuxia Lin; Xiaobo Li; Junfang He; Ping Zhang; Chao Liu
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

6.  Direct Activation of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification of Host Cell Lipid Metabolism.

Authors:  Nereida Jiménez de Oya; Ana-Belén Blázquez; Josefina Casas; Juan-Carlos Saiz; Miguel A Martín-Acebes
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

7.  Antivirals against (Re)emerging Flaviviruses: Should We Target the Virus or the Host?

Authors:  María-Jesús Pérez-Pérez; Juan-Carlos Saiz; Eva-María Priego; Miguel A Martín-Acebes
Journal:  ACS Med Chem Lett       Date:  2021-12-08       Impact factor: 4.345

Review 8.  Ceramide and Related Molecules in Viral Infections.

Authors:  Nadine Beckmann; Katrin Anne Becker
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 9.  Using Wolbachia to Eliminate Dengue: Will the Virus Fight Back?

Authors:  Kathryn M Edenborough; Heather A Flores; Cameron P Simmons; Johanna E Fraser
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

10.  The liver X receptor agonist LXR 623 restricts flavivirus replication.

Authors:  Luwanika Mlera; Danielle K Offerdahl; David W Dorward; Aaron Carmody; Abhilash I Chiramel; Sonja M Best; Marshall E Bloom
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.